
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
![]() | MicroAlgo Inc | 3.23 | 2.08 | 180.87% | 47,438,589 |
![]() | Universe Pharmaceuticals Inc | 0.2617 | 0.1192 | 83.65% | 73,839,035 |
![]() | EuroDry Ltd | 17.15 | 6.43 | 59.91% | 10 |
![]() | Forte Biosciences Inc | 17.09 | 6.39 | 59.72% | 2 |
![]() | First Seacoast Bancorp Inc | 17.25 | 6.31 | 57.68% | 6 |
![]() | United Homes Group Inc | 6.10 | 2.23 | 57.62% | 7 |
![]() | NaaS Technology Inc | 2.16 | 0.77 | 55.40% | 36,798,328 |
![]() | Texas Community Bancshares Inc | 24.00 | 7.85 | 48.61% | 12 |
![]() | Opthea Ltd | 7.15 | 2.16 | 43.29% | 9 |
![]() | Anika Therapeutics Inc | 24.99 | 7.34 | 41.59% | 34 |
![]() | Hawthorn Bancshares Inc | 46.99 | 13.35 | 39.68% | 17 |
BEIJING, Feb. 21, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that its board of directors (the "Board") has approved a share repurchase program (the "Share Repurchase Program"), effective from February 21, 2025. Pursuant to the Share Repurchase Program, the Company may repurchase up to US$10 million of its American depositary shares ("ADSs") over the next 12 months through the end of February 2026.
bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today announced that it has entered into a definitive agreement to be acquired by funds managed by global investment firms Carlyle (NASDAQ: CG) and SK Capital Partners, LP (“SK Capital”) in collaboration with a team of highly experienced biotech executives. David Meek, former CEO of Mirati Therapeutics and Ipsen, is expected to become CEO of bluebird upon closing. Carlyle and SK Capital will provide bluebird primary capital to scale bluebird’s commercial delivery of gene therapies for patients with sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy.
Bragg Gaming Group (NASDAQ: BRAG, TSX: BRAG) (“Bragg” or the “Company”) is pleased to announce that it has entered into an online casino content agreement with Canadian operator Loto-Québec, the only 100% legal and local casino site in the province of Loto-Québec.
Celsius Holdings, Inc. (Nasdaq: CELH) (“Celsius” or “the company”) today announced that it has entered into a definitive agreement to acquire Alani Nutrition LLC (“Alani Nu”) for $1.8 billion including $150 million in tax assets for a net purchase price of $1.65 billion, comprising a mix of cash and stock. The transaction will combine two growing, scaled brands in the U.S. energy drink category, creating a leading better-for-you, functional lifestyle platform that is well positioned to capitalize on the growing consumer preference for zero-sugar alternatives.
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
FNMA | Fannie Mae-No Politics | ||
RDGL | Vivos Inc | ||
HMBL | HUMBL Inc | ||
4 | NVDA | NVIDIA Corp | |
5 | MLGO | MicroAlgo Inc | |
6 | NBRI | North Bay Resources Inc |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
![]() | Bitcoin | 99,383.30 | 1,063.84 | 1.08% | 1.97T | 3,836,109,412 |
![]() | Ethereum | 2,834.60 | 96.29 | 3.52% | 342.4B | 1,913,595,937 |
![]() | Ripple | 2.69 | 0.00 | 0.00% | 155.38B | 773,934,690 |
![]() | Tether USD | 1.00 | 0.00 | 0.00% | 141.93B | 540,000,082 |
![]() | Binance Coin | 666.35 | 9.87 | 1.50% | 105.37B | 160,686,257 |
![]() | Solana | 179.35 | 3.32 | 1.89% | 88.13B | 936,267,727 |
![]() | USD Coin | 0.9999 | 0.0001 | 0.01% | 56.09B | 1,182,325,713 |
![]() | Dogecoin | 0.25947 | 0.00468 | 1.84% | 38.45B | 319,888,928 |
![]() | Cardano | 0.8127 | 0.009 | 1.12% | 29.15B | 149,468,264 |
![]() | stETH | 2,832.71 | 95.02 | 3.47% | 26.48B | 10,844,194 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions